VANCOUVER, BC — A Vancouver-based therapeutics company has begun a second Phase II trial of its novel long lasting non-opioid pain medication, with a specific focus on treating Chronic Scrotal… Read More
VANCOUVER, BC — Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, is pleased to announce Dr. Chris Bond has been promoted to… Read More
OTTAWA, ON — BioTalent Canada applauds the renewed commitment and investments made to skills in the country’s biotech and healthcare sectors in Budget 2023. The $197.7 million in the budget… Read More
MONTREAL, QC — Imagia Canexia Health announced today that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual… Read More
Marks the first time a Phase 2 trial has studied a cannabinol (CBN) formulation as a treatment option for any disease Data expected to be released in early calendar Q3… Read More
